KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 173 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 2.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $22 | -42.1% | 25,206 | -0.8% | 0.00% | – |
Q1 2024 | $38 | -99.9% | 25,406 | +149.9% | 0.00% | – |
Q3 2022 | $55,000 | -5.2% | 10,165 | -21.7% | 0.00% | – |
Q2 2022 | $58,000 | -39.6% | 12,990 | -0.8% | 0.00% | – |
Q1 2022 | $96,000 | +9.1% | 13,090 | -4.4% | 0.00% | – |
Q4 2021 | $88,000 | +18.9% | 13,690 | +7.5% | 0.00% | – |
Q3 2021 | $74,000 | -52.6% | 12,740 | +25.7% | 0.00% | – |
Q4 2020 | $156,000 | -18.8% | 10,134 | +0.8% | 0.00% | -100.0% |
Q4 2019 | $192,000 | +54.8% | 10,052 | -22.3% | 0.00% | 0.0% |
Q3 2019 | $124,000 | – | 12,937 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Delphi Management Partners VIII, L.L.C. | 2,263,006 | $13,170,000 | 9.51% |
Palo Alto Investors LP | 5,383,052 | $31,329,000 | 1.89% |
Birchview Capital, LP | 246,000 | $1,432,000 | 0.97% |
Lombard Odier Asset Management (Switzerland) SA | 1,517,804 | $8,834,000 | 0.55% |
Rubric Capital Management LP | 3,375,758 | $19,647,000 | 0.55% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,401,861 | $8,159,000 | 0.30% |
AlphaCentric Advisors LLC | 136,000 | $792,000 | 0.20% |
Bridgefront Capital, LLC | 20,946 | $122,000 | 0.13% |
Hennion & Walsh Asset Management, Inc. | 407,474 | $2,371,000 | 0.12% |
Virtus ETF Advisers LLC | 44,364 | $258,000 | 0.11% |